Media ReleasesSienna Cancer Diagnostics

View All Sienna Cancer Diagnostics News


Sienna Cancer Diagostics announces StatLab implementing strategies to increase hTERT sales in the USA

Melbourne, Australia, 21 May 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), a commercial stage, medical technology company, recently conducted a video interview with Wayne Rigler, Executive Vice-President of Sales & Marketing for StatLab. The video provides shareholders with an update on the sales and marketing efforts of StatLab, Sienna’s exclusive distributor in the United States.

For further information please download PDF attached:
Download this document